Gene: TSLP
Official Full Name: thymic stromal lymphopoietinprovided by HGNC
Gene Summary: This gene encodes a hemopoietic cytokine proposed to signal through a heterodimeric receptor complex composed of the thymic stromal lymphopoietin receptor and the IL-7R alpha chain. It mainly impacts myeloid cells and induces the release of T cell-attracting chemokines from monocytes and enhances the maturation of CD11c(+) dendritic cells. The protein promotes T helper type 2 (TH2) cell responses that are associated with immunity in various inflammatory diseases, including asthma, allergic inflammation and chronic obstructive pulmonary disease. The protein is therefore considered a potential therapeutic target for the treatment of such diseases. In addition, the shorter (predominant) isoform is an antimicrobial protein, displaying antibacterial and antifungal activity against B. cereus, E. coli, E. faecalis, S. mitis, S. epidermidis, and C. albicans. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2020]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11130 | TSLP Knockout cell line (HEK293) | Human | TSLP | 1:3~1:6 | Negative | Online Inquiry |
TSLP Gene Knockout Cell Lines are engineered cellular models that provide powerful tools for elucidating the role of the thymic stromal lymphopoietin (TSLP) gene in various biological processes. These cell lines have undergone precise genome editing to create a knockout phenotype, effectively disabling TSLP expression and allowing researchers to investigate the downstream effects of its absence. The knockout mechanism is typically achieved through CRISPR-Cas9 technology, which provides a highly efficient method for targeted gene disruption.
The TSLP gene plays a critical role in the immune response, particularly in mediating allergic reactions and inflammatory conditions. By utilizing TSLP Gene Knockout Cell Lines, scientists can explore TSLP’s involvement in pathophysiological states, including asthma and atopic dermatitis, thereby gaining insights into potential therapeutic targets. These cell lines facilitate functional assays to assess changes in cytokine production, cellular differentiation, and overall immune modulation in response to various stimuli.
One of the hallmark advantages of TSLP Gene Knockout Cell Lines is their specificity and reliability compared to alternative models, such as transient knockdown systems. The stable gene knockout not only allows for long-term studies but also minimizes off-target effects that can confound results. This precision enhances the reproducibility of experiments and the robustness of data collected, making it invaluable for both academic research and clinical applications.
Researchers and clinicians are increasingly recognizing the significance of TSLP in immune regulation, making these knockout cell lines essential in developing novel interventions and understanding immune-related diseases. Our company’s deep expertise in gene editing technologies and commitment to quality ensures that these cell lines meet the highest standards, supporting your research with confidence and excellence. Whether investigating basic biological mechanisms or advancing therapeutic solutions, TSLP Gene Knockout Cell Lines represent a significant advancement in the study of immune responses and diseases.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.